Cargando…
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets
Humanity did surprisingly well so far, considering how unprepared it was to respond to the coronavirus disease 2019 (COVID-19) threat. By blending old and ingenious new technology in the context of the accumulated knowledge on other human coronaviruses, several vaccine candidates were produced and t...
Autores principales: | Nowill, Alexandre E., Caruso, Manuel, de Campos-Lima, Pedro O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303130/ https://www.ncbi.nlm.nih.gov/pubmed/37388738 http://dx.doi.org/10.3389/fimmu.2023.1133225 |
Ejemplares similares
-
What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?
por: López, Carolina, et al.
Publicado: (2017) -
Tick Immune System: What Is Known, the Interconnections, the Gaps, and the Challenges
por: Fogaça, Andréa C., et al.
Publicado: (2021) -
LHCb Run II : what should be known by the end of 2018
por: Vagnoni, Vincenzo
Publicado: (2015) -
Plasmodium vivax vaccine: What is the best way to go?
por: da Veiga, Gisele Tatiane Soares, et al.
Publicado: (2023) -
A course on optimization and best approximation
por: Holmes, Richard B
Publicado: (1972)